Medications
GLP-1s integrated with metabolic program
Monthly Cost
Employer-covered
Speed to Start
Moderate
Trustpilot
Not yet rated
Est. 2014
About Virta Health
Virta Health was founded in 2014 with a mission that remains unique in digital health: reversing type 2 diabetes through nutritional intervention, specifically a physician-supervised ketogenic diet. The company has published peer-reviewed research demonstrating that its approach can reduce or eliminate the need for diabetes medications in a significant percentage of patients. When GLP-1 medications emerged as powerful tools for metabolic health, Virta integrated them into its existing clinical framework — not as a replacement for its nutrition-first philosophy, but as a complementary tool for patients who need pharmacological support alongside dietary change.
Like Omada, Virta primarily delivers its program through employer and health plan partnerships, meaning most patients access the platform at no direct cost. The program includes a dedicated physician or nurse practitioner, a registered dietitian, comprehensive lab testing (including metabolic panels and A1C monitoring), and continuous remote monitoring through connected devices. GLP-1 medications are prescribed when clinically appropriate, but they are always framed within Virta’s broader metabolic health protocol. This integrated approach is designed to produce sustainable results even if medication is eventually discontinued.
Virta’s clinical support level is among the highest in the telehealth weight loss space. Patients have direct messaging access to their care team, regular check-ins, and a structured nutrition curriculum that evolves as metabolic markers improve. The program tracks biomarkers over time, adjusting both dietary recommendations and medication as needed. For patients with type 2 diabetes or prediabetes, this level of metabolic management goes far beyond what a standard GLP-1 prescription service offers. Virta’s published outcomes include an average A1C reduction of 1.3% and significant reductions in diabetes medication use at one year.
One important consideration is Virta’s C- rating with the Better Business Bureau, which is notably lower than its clinical reputation might suggest. BBB ratings reflect complaint resolution processes and business responsiveness, not clinical quality, and Virta’s lower grade appears tied to customer service friction rather than medical concerns. The company does not have a Trustpilot presence, so independent consumer sentiment data is limited. Our editorial team recommends prospective patients weigh the strong clinical evidence alongside the BBB rating when making their decision.
Virta is not a simple GLP-1 prescription service — it is a comprehensive metabolic health program that may include GLP-1 medications as one component. Patients who want quick, standalone access to semaglutide or tirzepatide without dietary commitments will find Virta’s model more intensive than they need. But for patients with metabolic conditions who want a physician-led, nutrition-integrated approach with rigorous lab monitoring, Virta offers a depth of care that few telehealth platforms can match.
Virta Health GLP-1 Medications
At a Glance
Medications Offered
GLP-1s integrated with metabolic program
Medication support / GLP-1 integrated with nutrition-first program
Cost & Insurance
- Monthly: Employer-covered
- 6-month estimate: Employer-covered
- Insurance: Employer / health-plan sponsored
- Self-pay: No clear broad self-pay program identified
Clinical Features
- Lab testing: Yes
- Dietitian access: Yes
- Verified Pharmacy: N/A — Brand-name integrated with metabolic program
- BBB Rating: C-
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Moderate
- Spanish-speaking providers: Not available
What the Virta Intake Looks Like
We walked through Virta’s enrollment intake ourselves on April 29, 2026. Virta’s intake reads differently from every other entry in our catalog: the word “GLP-1” never appears in the 23 online screens. Virta is a metabolic-disease and type-2-diabetes-reversal program that prescribes GLP-1 medications when clinically appropriate — the actual prescribing decision is deferred to a 20-minute live video visit with an Enrollment Nurse, scheduled at the end of the funnel.
Most comprehensive lifestyle and comorbidity screen in our catalog — anxiety AND depression named explicitly, AUDIT-C-style alcohol quantity scale, 4-tier tobacco frequency, food allergies separated from medication allergies, family history with autoimmune disease, comprehensive surgery history. The deduction is the absence of GLP-1-specific FDA black-box questions (MTC, MEN-2, pancreatitis are not asked in the online form) — those are deferred to the live nurse visit.
Moderate. 23 screens is long, real phone OTP and USPS address verification add legitimate friction, and the mandatory 20-minute live video visit before any prescription means the patient cannot get GLP-1 same-day. Pricing is not visible in the funnel — opaque until the nurse visit. No fake-urgency timers, no testimonial walls. A starter kit (scale, meter, recipes, guides) ships at enrollment.
The 14 Stages
Virta is structurally different from a direct-to-consumer GLP-1 platform. The 23 online screens cover demographics, comorbidities, family and surgery history, medications, allergies, lifestyle, race/ethnicity, and address — but they do not ask the GLP-1-specific FDA-black-box questions (MTC, MEN-2, pancreatitis personal history) and they do not let the patient select a medication. Those questions and the prescribing decision are handled in a mandatory 20-minute live video visit with an Enrollment Nurse that the patient schedules at the end of the funnel. Virta’s enrollment is best understood as a metabolic-disease program intake; GLP-1 is one of several tools the clinical team may prescribe based on the live visit.
Unlike sponsor-gated programs that refuse entry to patients without an employer benefit, Virta’s screen-3 access selector explicitly offers “I will pay out-of-pocket” alongside “I am covered by an employer or health plan” and “I am a U.S. veteran.” Selecting out-of-pocket continues the funnel cleanly through to the live visit booking. Pricing is not revealed inside the online flow — it is presumably surfaced during the Enrollment Nurse visit, which is a downside for patients who want to compare costs before investing 30+ minutes in the program.
Virta is one of very few platforms in our catalog that surfaces anxiety and depression as named options in the comorbidity multi-select. Most direct-to-consumer GLP-1 funnels skip mental health entirely, or bury suicidality inside an unrelated checklist (we documented Rex MD doing this with a GI multi-select). Virta still does not ask a validated PHQ-2 or PHQ-9 instrument and does not ask suicidality directly — the questions are checkbox depth, not scored screeners — but naming the conditions in the same list as cancer, kidney disease, and CHF treats them as legitimate clinical concerns rather than taboo.
Most GLP-1 platforms ask alcohol and tobacco as Y/N or a single-checkbox option. Virta asks quantity for alcohol (none / 1-or-less per day / 2 / more than 2 — closest in our catalog to the validated AUDIT-C scale) and frequency for tobacco (never / quit completely / occasionally / about every day). Combined with the separated medication-vs-food allergy questions and the Race + Ethnicity two-question CDC convention, Virta’s intake reads more like a structured medical intake than the casual lifestyle prompts most cash-pay funnels use.
No medullary thyroid cancer (MTC) personal or family history. No MEN-2 by name. No pancreatitis as a separate question (only “pancreas surgery” appears in the surgery list). No eating-disorder screen. No pregnancy or breastfeeding question. No GLP-1 medication allergy by drug name. No diet history depth or exercise history depth. No validated PHQ-2/PHQ-9 or suicidality. No government ID upload. No blood pressure or resting heart rate reading. These gaps are presumably filled during the live nurse visit, but a patient stopping at the online intake is not yet medically screened for GLP-1 candidacy in the way a Hims, Ro, or GobyMeds funnel would have screened them.
Virta ships a starter kit at enrollment containing a connected scale, meter, recipes, and guides. The address screen states this directly: “When you complete enrollment, we will send you a starter kit with a scale, meter, recipes and guides.” This is consistent with Virta’s metabolic-monitoring model (originally built for type-2-diabetes reversal via nutritional ketosis) but is a meaningful overhead for a patient who simply wants a fast cash-pay GLP-1 prescription. Combined with the mandatory 20-minute live nurse visit, expect 30+ minutes of funnel time plus a multi-day wait for the visit slot — Virta is not a same-day path.
Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the Virta enrollment intake using a representative GLP-1 candidate persona on the self-pay path and stopped before scheduling the Clinical Video Visit. The word “GLP-1” did not appear in the 23 online screens we walked.
Opens virtahealth.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
Start your GLP-1 weight loss journey with Virta Health today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
